BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22334898)

  • 1. [The possibilities of surgical treatment of hepatocellular cancer in patients with liver cirrhosis].
    Patiutko IuI; Chuchuev ES; Podluzhnyĭ DV; Agafonova MG
    Khirurgiia (Mosk); 2011; (10):13-9. PubMed ID: 22334898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical treatment of hepatocellular carcinoma].
    Patiutko IuI; Chuchuev ES; Gakhramanov AD; Sagaĭdak IV; Kotel'nikov AG; Podluzhnyĭ DV; Abgarian MG; Poliakov AN; Konovalov AM
    Klin Khir; 2011 Sep; (9):26-30. PubMed ID: 22168020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma.
    Li JX; Wu H; Huang JW; Zeng Y
    J Formos Med Assoc; 2012 Sep; 111(9):510-5. PubMed ID: 23021508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
    Xue T; Le F; Chen R; Xie X; Zhang L; Ge N; Chen Y; Wang Y; Zhang B; Ye S; Ren Z
    Med Oncol; 2015 Mar; 32(3):64. PubMed ID: 25682389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria.
    Liu H; Wang ZG; Fu SY; Li AJ; Pan ZY; Zhou WP; Lau WY; Wu MC
    Br J Surg; 2016 Mar; 103(4):348-56. PubMed ID: 26780107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hepatocellular carcinoma in the age of liver transplantation.
    Martin AP
    Int J Surg; 2009 Aug; 7(4):324-9. PubMed ID: 19643691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?
    Allard MA; Sebagh M; Ruiz A; Guettier C; Paule B; Vibert E; Cunha AS; Cherqui D; Samuel D; Bismuth H; Castaing D; Adam R
    J Hepatol; 2015 Jul; 63(1):83-92. PubMed ID: 25646884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current surgical treatment strategies for hepatocellular carcinoma in North America.
    Khan AS; Fowler KJ; Chapman WC
    World J Gastroenterol; 2014 Nov; 20(41):15007-17. PubMed ID: 25386049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Survival in Hepatocellular Carcinoma Patients.
    Gokcan H; Savaş N; Oztuna D; Moray G; Boyvat F; Haberal M
    Ann Transplant; 2015 Oct; 20():596-603. PubMed ID: 26438974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: experience from a Danish tertiary liver center.
    Bharadwaz A; Bak-Fredslund KP; Villadsen GE; Nielsen JE; Simonsen K; Sandahl TD; Grønbæk H; Nielsen DT
    Acta Radiol; 2016 Jul; 57(7):844-51. PubMed ID: 26342009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
    J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprocedural complications by Child-Pugh class in patients undergoing transcatheter arterial embolization or chemoembolization to treat unresectable hepatocellular carcinoma at a VA medical center.
    Russell JS; Sawhney R; Monto A; Nanavati S; Davoren JB; Aslam R; Corvera CU
    Am J Surg; 2010 Nov; 200(5):659-64. PubMed ID: 21056149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
    Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
    J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of treatment of primary liver cancer at Kaunas University of Medicine Hospital.
    Jievaltas M; Stoskuviene L; Petrenkiene V; Barauskas G; Pundzius J
    Medicina (Kaunas); 2004; 40(2):127-34. PubMed ID: 15007271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of cirrhosis should determine the operative modality for patients with early hepatocellular carcinoma and compensated liver function.
    Huang ZY; Liang BY; Xiong M; Dong KS; Zhang ZY; Zhang EL; Li CH; Chen XP
    Surgery; 2016 Feb; 159(2):621-31. PubMed ID: 26453137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency and safety of radiofrequency-assisted hepatectomy for hepatocellular carcinoma with cirrhosis: A single-center retrospective cohort study.
    Zhang F; Yan J; Feng XB; Xia F; Li XW; Ma KS; Bie P
    World J Gastroenterol; 2015 Sep; 21(35):10159-65. PubMed ID: 26401080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child-Pugh grade A cirrhosis.
    Zhou SJ; Zhang EL; Liang BY; Zhang ZY; Dong KS; Hou P; Chen XP; Xiong M; Huang ZY
    J Surg Res; 2016 Feb; 200(2):444-51. PubMed ID: 26470819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.